Свободно-циркулирующие нуклеиновые кислоты как диагностический биомаркер онкологических заболеваний

2018

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.26577/eb-2018-1-1316
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

In the last decade, one of the most important trends of modern science is the search of the biomarkers, which would have high sensitivity and specificity for non-invasive diagnostics of cancer diseases. Immunological methods are not a well established practice in cancer diagnostics because of low specificity of currently used tumor markers. The study of free - circulating nucleic acids in plasma and serum of cancer patients represents a promising direction of modern molecular diagnostics. Free - circulating nucleic acids include DNA, RNA, microRNA, viral DNA / RNA and mitochondrial DNA. In this case, free-circulating nucleic acids can be present both in the free form and in the supramolecular nucleoprotein complexes. However, many aspects related to the biogenesis of free-circulating nucleic acids, as well as their role in the mechanism of carcinogenesis, are still not clear. This review focuses on the biological properties of free - circulating nucleic acids, biogenesis, their role in the pathogenesis of cancer and the possibility of using free - circulating nucleic acids as biomarkers in the diagnosis of cancer. Key words: free circulating nucleic acids, free circulating DNA, microRNA, mitochondrial DNA, cancer, biomarkers.